SCHEMBL9719345

SCHEMBL9719345

CN1C(=O)C(Cc2ccncc2)c2ccccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ROCK2 O75116 3/20 0.51
NPSR1 Q6W5P4 2/20 0.50
CES2 O00748 2/20 0.43
ALDH1A1 P00352 3/20 0.43
KDM4E B2RXH2 1/20 0.43
HPGD P15428 1/20 0.43
EGFR P00533 1/20 0.42
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
KDM4C Q9H3R0 1/20 0.40
ROCK1 Q13464 1/20 0.40
ALOX5 P09917 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ELANE P08246 2/20 0.38
MDM2 Q00987 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4599210 0.80 ALDH1A1 (0.48) ROCK2NPSR1CES2ALDH1A1MEN1
Hydrochloric Acid SCHEMBL8805740 0.79 MAPK1 (0.48) ROCK2NPSR1CES2ALDH1A1MEN1
SCHEMBL8873146 0.76 ROCK2 (0.36) ROCK2CES2ALDH1A1MEN1KMT2A
SCHEMBL24664741 0.76 ALDH1A1 (0.65) NPSR1CES2ALDH1A1KDM4EHPGD
SCHEMBL8873892 0.74 MAPT (0.39) ROCK2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL7811327 0.74 ALDH1A1 (0.37) ROCK2NPSR1ALDH1A1MEN1KMT2A
SCHEMBL9719342 0.74 ALOX5 (0.47) ROCK2ALDH1A1KDM4EMEN1KMT2A
SCHEMBL5667766 0.74 EGFR (0.50) NPSR1CES2EGFRMEN1KMT2A
SCHEMBL31613810 0.74 EGFR (0.50) NPSR1CES2EGFRMEN1KMT2A
SCHEMBL8488571 0.73 ALDH1A1 (0.53) NPSR1ALDH1A1KDM4EHPGDEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992000760-A1 METHOD OF TREATING NEUROLOGICAL DYSFUNCTION USING NEUROTRANSMITTER ENHANCES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-01-23 WO disclosed